Literature DB >> 17400415

Comparison of demographic and clinical characteristics between opioid-dependent individuals admitted to a community-based treatment setting and those enrolled in a research-based treatment setting.

C Patrick Carroll1, Michael Kidorf, Eric C Strain, Robert K Brooner.   

Abstract

Despite the significant developments in pharmacotherapy and behavioral treatments for addiction, the dissemination of new treatment methods into the community has been slow. It has been pointed out that treatments developed in research settings may be impractical in community treatment settings, which might help explain the transition lag. Screening and recruitment of participants for research studies might partially explain this, as there is evidence that substance-abusing individuals who participate in clinical research are different on a number of measures from treatment seekers. However, no study has directly compared treatment seekers with research participants drawn from similar populations using prospective methods. This study compared the demographic characteristics, drug use and psychosocial problem severity levels, and personality traits of opioid-dependent individuals seeking help in a community setting (n = 502) with those of opioid-dependent individuals in a primarily research-based drug abuse treatment setting (n = 459); both settings offered a similar set of treatment services (opioid agonist medication and counseling). Although the overall findings revealed numerous similarities between the groups, differences were also observed. Most notably, there were significantly fewer women in the research sample than in the community-based treatment sample. Other differences included a modest but statistically significant increase in psychosocial problem severity levels in the community-based treatment sample and higher drug use problem severity levels in the research sample. Interestingly, many of these differences were strongest in women as compared with men.

Entities:  

Mesh:

Year:  2007        PMID: 17400415      PMCID: PMC2174264          DOI: 10.1016/j.jsat.2006.12.014

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  42 in total

1.  Treatment of heroin-dependent poly-drug abusers with contingency management and buprenorphine maintenance.

Authors:  K K Downey; T C Helmus; C R Schuster
Journal:  Exp Clin Psychopharmacol       Date:  2000-05       Impact factor: 3.157

2.  Contingency management to enhance naltrexone treatment of opioid dependence: a randomized clinical trial of reinforcement magnitude.

Authors:  Kathleen M Carroll; Rajita Sinha; Charla Nich; Theresa Babuscio; Bruce J Rounsaville
Journal:  Exp Clin Psychopharmacol       Date:  2002-02       Impact factor: 3.157

3.  Short-term stability of NEO-PI-R personality trait scores in opioid-dependent outpatients.

Authors:  J A Carter; J H Herbst; K B Stoller; V L King; M S Kidorf; P T Costa; R K Brooner
Journal:  Psychol Addict Behav       Date:  2001-09

4.  Comparing adaptive stepped care and monetary-based voucher interventions for opioid dependence.

Authors:  Robert K Brooner; Michael S Kidorf; Van L King; Kenneth B Stoller; Karin J Neufeld; Ken Kolodner
Journal:  Drug Alcohol Depend       Date:  2007-01-24       Impact factor: 4.492

5.  Buprenorphine: a controlled clinical trial in the treatment of opioid dependence.

Authors:  P P Pani; I Maremmani; R Pirastu; A Tagliamonte; G L Gessa
Journal:  Drug Alcohol Depend       Date:  2000-07-01       Impact factor: 4.492

6.  Intimate violence and post-traumatic stress disorder among individuals with cocaine dependence.

Authors:  B S Dansky; C A Byrne; K T Brady
Journal:  Am J Drug Alcohol Abuse       Date:  1999-05       Impact factor: 3.829

7.  Use of exclusion criteria in selecting research subjects and its effect on the generalizability of alcohol treatment outcome studies.

Authors:  K Humphreys; C Weisner
Journal:  Am J Psychiatry       Date:  2000-04       Impact factor: 18.112

8.  Contingency management in outpatient methadone treatment: a meta-analysis.

Authors:  J D Griffith; G A Rowan-Szal; R R Roark; D D Simpson
Journal:  Drug Alcohol Depend       Date:  2000-02-01       Impact factor: 4.492

9.  Gender differences in drug treatment careers among clients in the national Drug Abuse Treatment Outcome Study.

Authors:  C E Grella; V Joshi
Journal:  Am J Drug Alcohol Abuse       Date:  1999-08       Impact factor: 3.829

10.  Treating cocaine-using methadone patients: predictors of outcomes in a psychosocial clinical trial.

Authors:  Stephen Magura; Andrew Rosenblum; Chunki Fong; Cherie Villano; Beverly Richman
Journal:  Subst Use Misuse       Date:  2002       Impact factor: 2.164

View more
  2 in total

1.  Measurement of self-reported HIV risk behaviors in injection drug users: comparison of standard versus timeline follow-back administration procedures.

Authors:  Marc L Copersino; Christina S Meade; George E Bigelow; Robert K Brooner
Journal:  J Subst Abuse Treat       Date:  2009-08-29

2.  Sleep problems reported by patients entering opioid agonist treatment.

Authors:  Christopher K Burke; Jessica M Peirce; Michael S Kidorf; David Neubauer; Naresh M Punjabi; Kenneth B Stoller; Steve Hursh; Robert K Brooner
Journal:  J Subst Abuse Treat       Date:  2008-01-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.